Article
Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette--Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity.
Clinical and experimental immunology - 1 Jul 2014
Newton M R, Askeland E J, Andresen E D, Chehval V A, Wang X, Askeland R W, O'Donnell M A, Luo Y
Abstract excerpt
Effective treatment of bladder cancer with bacillus Calmette-Guérin (BCG) depends on the induction of a T helper type (Th) 1 immune response. Interleukin (IL)-10 down-regulates the Th1 response and is associated with BCG failure. In this study, we investigated whether blocking IL-10 signalling could enhance the BCG-induced Th1 response and anti-tumour immunity in a murine orthotopic tumour model. Treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.